GROWTH INVESTING News & Analysis

This healthcare company still has plenty of growth potential, but it’s been a rocky road for investors recently.

Cochlear’s biggest market segment has matured and it is looking elsewhere for growth.

Monster's share price is up over 18 times since I first came across its products in the late noughties. What can we learn from its rise?

And our equity analysts’ outlook for the stocks.

While many chase high yields, true investment power lies in companies that steadily grow dividends. This strategy, rooted in patience and discipline,...

Niche play with more growth potential than many investors give it credit for.

Shares in the streaming giant don’t look especially cheap, even if management achieves its ambitious goals for 2030.

The stocks of these high-quality growth companies look undervalued today.

These shares have been left for dead, yet both companies appear to have secular tailwinds in their favour.

This new monthly feature is dedicated to helping you grow your passive income and take another step towards financial freedom.